News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
India’s Strides Arcolab Limited Gets US Nod For HIV Tab Nevirapine
August 16, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MUMBAI, Aug 16 (Reuters) - India's Strides Arcolab Ltd. (STAR.BO: Quote, Profile, Research) said on Wednesday it had received tentative approval from the U.S. Food and Drug Administration for its HIV drug nevirapine in tablet forms.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Asia
MORE ON THIS TOPIC
CDC
Republicans Ratchet Up Pressure as Monarez Levels Damning Allegations Against Kennedy
September 17, 2025
·
4 min read
·
Heather McKenzie
FDA
FDA’s Ad Crackdown Targets Novo, Lilly’s Oprah Special on GLP-1s
September 17, 2025
·
3 min read
·
Annalee Armstrong
Podcast
China Crackdown, UK Exit, Novo Layoffs, Adcomm Flip Flop, More
September 17, 2025
·
2 min read
·
Heather McKenzie
Obesity
Novo, Lilly Jostle For Market Lead in Obesity With New Regulatory Efforts
September 16, 2025
·
2 min read
·
Tristan Manalac